Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course

Digestive and Liver Disease

Volumn 39, Issue 7, 2007, Pages 610-616

  Kim, B C ^a   Park, S ^a   Han, J ^a   Kim, J H ^a   Kim, T I ^a   Kim, W H ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Anti Saccharomyces cerevisiae antibody (ASCA); Crohn's disease; Harvey Bradshaw index; Vienna classification

Indexed keywords

FUNGUS ANTIBODY; IMMUNOSUPPRESSIVE AGENT; SACCHAROMYCES CEREVISIAE ANTIBODY; STEROID; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DIAGNOSTIC TEST; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; GASTROINTESTINAL SURGERY; HOSPITAL ADMISSION; HUMAN; IMMUNOFLUORESCENCE; KOREA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHENOTYPE;

ADOLESCENT; ADULT; ANTIBODIES, FUNGAL; BIOLOGICAL MARKERS; CROHN DISEASE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; KOREA; MALE; PHENOTYPE; SACCHAROMYCES CEREVISIAE; SEVERITY OF ILLNESS INDEX;

EID: 34250021829     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.03.006     Document Type: Article

References (31)

1. Friedman S., and Blumberg R.S. Inflammatory bowel disease. In: Kasper D.L., Braunwald E., Fauci A.S., et al. (Eds). Harrison's Principles of internal medicine. 16th ed. (2005), McGraw-Hill, Seoul 1776-1789
2. Main J., McKenzie H., Yeaman G.R., Kerr M.A., Robson D., Pennington C.R., et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. Br Med J 297 (1988) 1105-1106
3. Sendid B., Colombel J.F., Jacquinot P.M., Faille C., Fruit J., Cortot A., et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 3 (1996) 219-226
4. Vasiliauskas E.A., Kam L.Y., Karp L.C., Gaiennie J., Yang H., Targan S.R., et al. Marker antibody expression stratifies Crohn's disease into immunologically homogenous subgroups with distinct clinical characteristics. Gut 47 (2000) 487-496
5. Vermeire S., Peeters M., Vlietinck R., Joossens S., Den Hond E., Bulteel V., et al. Anti-Saccharomyces antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 7 (2001) 8-15
6. Ruemmele F.M., Targan S.R., Levy G., Dubinsky M., Braun J., Seidman E.G., et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 115 (1998) 822-829
7. Yao T. Criteria for diagnosis of Crohn's disease (preliminary proposal). In: Muto T. (Ed). Annual report of the Research Committee of Inflammatory Bowel Disease (1996), The Ministry of Health and Welfare of Japan, Tokyo 63-66
8. Yao T., Matsui T., and Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 10 Suppl. (2000) S85-S93
9. Klebl F.H., Bataille F., Bertea C.R., Herfarth H., Hofstädter F., Schölmerich J., et al. Association of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies with Vienna classification subtypes of Crohn's disease. Inflamm Bowel Dis 9 (2003) 302-307
10. Klebl F.H., Bataille F., Hofstadter F., Herfarth H., Scholmerich J., and Rogler G. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease. Int J Colorectal Dis 19 (2004) 319-324
11. Seibold F., Stich O., Hufnagl R., Kamil S., and Scheurlen M. Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 36 (2001) 196-201
12. Sandborn W.J., Feagan B.G., Hanauer S.B., Lochs H., Lofberg R., Modigliani R., et al. A review of activity indices and efficacy endpoints for clinical trials medical therapy in adults with Crohn's disease. Gastroenterology 122 (2002) 512-530
13. Gasche C., Scholmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., et al. A simple classification of Crohn's disease; report of working party for the world congress of gastroenterology, Vienna 1998. Inflamm Bowel Dis 6 (2000) 8-15
14. Sostegni R., Daperno M., Ercole E., Rigazio C., Bresso F., Masoero G., et al. Detection of anti-Saccharomyces cerevisiae antibodies in Crohn's disease: is it a reliable diagnostic and prognostic marker?. Dig Liver Dis 33 (2001) 755-761
15. Moore M.M., Fabricatorian D., and Selby W.S. Assessment and relevance of enzyme-linked immunosorbent assay for antibodies to Saccharomyces cerevisiae in Australian patients with inflammatory bowel disease. Intern Med J 32 (2002) 349-352
16. Koutroubakis I.E., Petinaki E., Mouzas I.A., Vlachonikolis I.G., Anagnostopoulou E., Castanas E., et al. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastrenterol 96 (2001) 449-454
17. Quinton J.F., Sendid B., Reumaux D., Duthilleul P., Cortot A., Grandbastien B., et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42 (1998) 788-791
18. Kim B.G., Kim Y.S., Kim J.S., Jung H.C., and Song I.S. The diagnostic role of anti-Saccharomyces cerevisise antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis Colon Rectum 45 (2002) 1062-1069
19. Kim J.E., Kim K.S., and Seo J.K. Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease. Korean J Gastroenterol 42 (2003) 297-302 [in Korean]
20. Halfvarson J., Standaert-Vitse A., Jarnerot G., Sendid B., Jouault T., Bonin L., et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut 54 (2005) 1237-1243
21. Hisabe T., Matsui T., Sakurai T., Murakami Y., Tanabe H., Matake H., et al. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J Gastroenterol 38 (2003) 121-126
22. Reumaux D., Sendid B., Poulain D., Duthilleul P., Dewit O., and Colombel J.F. Serological markers in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 17 (2003) 19-35
23. Norman G.L. Anti-Saccharomyces cerevisiae antibodies in inflammartory bowel disease. Clin Appl Immunol Rev 2 (2001) 45-63
24. Bernstein C.N., Orr K., Blanchard J.F., Sargent M., and Workman D. Development of an assay for antibodies to Saccharomyces cerevisiae: easy, cheap and specific for Crohn's disease. Can J Gastroenterol 15 (2001) 499-504
25. Sachar D.B., Subramani K., Mauer K., Rivera-MacMurray S., Turtel P., Bodian C.A., et al. Patterns of postoperative recurrence in fistulizing and stenotic Crohn's disease: a retrospective cohort study of 71 patients. J Clin Gastroenterol 22 (1996) 114-116
26. Canani R.B., Romano M.T., Greco L., Terrin G., Sferlazzas C., Barabino A., et al. Effect of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn's disease. Inflamm Bowel Dis 10 (2004) 234-239
27. Dubinsky M.C., and Seidman E.G. Diagnostic markers of inflammatory bowel disease. Curr Opin Gastroenterol 16 (2000) 337-342
28. Polito II J.M., Childs B., Mellits E.D., Tokayer A.Z., Harris M.L., and Bayless T.M. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 111 (1996) 580-586
29. Colombel J.F., Grandbastien B., Gower-Rousseau C., Plegat S., Evrard J.P., Dupas J.L., et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111 (1996) 604-607
30. Forcione D.G., Rosen M.J., Kisiel J.B., and Sands B.E. Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease. Gut 53 (2004) 1117-1122
31. Choi C.H., Kim T.I., Kim B.C., Shin S.J., Lee S.K., Kim W.H., et al. Anti-Saccharomyces cerevisiae antibody in intestinal Behcet's disease patients: relation to clinical course. Dis Colon Rectum 49 (2006) 1849-1859